Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(CSE:
MBIO
)
0.8800
UNCHANGED
Streaming Delayed Price
Updated: 3:56 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.8800
Bid (Size)
0.6900 (500)
Ask (Size)
1.130 (200)
Prev. Close
0.8800
Today's Range
0.8800 - 0.8800
52wk Range
0.0050 - 2.150
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Via
TheNewswire.com
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
One of two Phase 2B trials currently dosing and underway:
Via
TheNewswire.com
Performance
YTD
+4300.0%
+4300.0%
1 Month
+17500.0%
+17500.0%
3 Month
+17500.0%
+17500.0%
6 Month
+8700.0%
+8700.0%
1 Year
+3420.0%
+3420.0%
More News
Read More
MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials
August 19, 2024
Via
ACCESSWIRE
MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory
August 01, 2024
Via
ACCESSWIRE
Mindbio Therapeutics CEO Issues Letter To Shareholders
July 08, 2024
Via
ACCESSWIRE
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
April 30, 2024
Via
ACCESSWIRE
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
April 22, 2024
Via
ACCESSWIRE
MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials
June 20, 2024
Via
ACCESSWIRE
MindBio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial
June 12, 2024
Via
ACCESSWIRE
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
May 14, 2024
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
May 14, 2024
Via
ACCESSWIRE
MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
May 02, 2024
Via
ACCESSWIRE
MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3
May 01, 2024
Via
ACCESSWIRE
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
↗
April 30, 2024
Via
Benzinga
Lender Requests to Convert Loan to MindBio Shares
April 16, 2024
Via
ACCESSWIRE
MindBio Begins Landmark Phase 2B Take-Home Microdosing (MB22001) Clinical Trial in Patients with Major Depressive Disorder
March 20, 2024
Via
ACCESSWIRE
MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
March 04, 2024
Via
ACCESSWIRE
MindBio Therapeutics Announces Positive Depression Data from World-First Phase 2a Take-Home Microdosing Trial
February 25, 2024
Via
ACCESSWIRE
MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial
February 13, 2024
Via
ACCESSWIRE
MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients
January 29, 2024
Via
ACCESSWIRE
MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
December 20, 2023
Via
ACCESSWIRE
MindBio Therapeutics Team Members Honoured with Industry Leading Awards
November 21, 2023
Via
ACCESSWIRE
MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
October 31, 2023
Via
ACCESSWIRE
MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
October 28, 2023
Via
ACCESSWIRE
Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
October 26, 2023
Via
ACCESSWIRE
Frequently Asked Questions
Is MBIO publicly traded?
Yes, MBIO is publicly traded.
What exchange does MBIO trade on?
MBIO trades on the Canadian Securities Exchange
What is the ticker symbol for MBIO?
The ticker symbol for MBIO is MBIO on the Canadian Securities Exchange
What is the current price of MBIO?
The current price of MBIO is 0.8800
When was MBIO last traded?
The last trade of MBIO was at 11/21/25 03:56 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today